Mussa S, Drury NE, Stickley J, Khan NE, Jones TJ, Barron DJ and Brawn WJ. Mentoring new surgeons: can we avoid the learning curve? Eur J Cardiothorac Surg 2016 (in press).
Chong C-R*, Drury NE*, Licari G, Frenneaux MP, Horowitz JD, Pagano D and Sallustio BC. Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium. Eur J Clin Pharmacol 2015;71:1485-91.
Senanayake EL, Howell NJ, Ranasinghe AM, Drury NE, Freemantle N, Frenneaux MP et al., Oelofse T, Green DH, Wilson IC, Rooney SJ, Mascaro JG, Graham TR, Bhudia SK, Lewis ME and Pagano D. Multi-centre double-blinded randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery. Eur J Cardiothorac Surg 2015; 48: 354-62.
Arif S, Borgognone A, Lin EL, O’Sullivan AG, Sharma V, Drury NE, Menon A, Nightingale P, Mascaro J, Bonser RS, Horowitz JD, Feelisch M, Frenneaux MP and Madhani M. Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans. Br J Pharmacol 2015; 172: 3341-52.
Drury NE, Howell NJ, Calvert MJ, Weber RJM, Senanayake EL, Lewis ME, Hyde JAJ, Green DH, Mascaro JG, Wilson IC, Graham TR, Rooney SJ, Viant MR, Freemantle N, Frenneaux MP and Pagano D on behalf of the CASPER trial investigators. The effect of Perhexiline on myocardial protection during coronary artery surgery: a two-centre randomised double-blind placebo-controlled trial. Eur J Cardiothorac Surg 2015; 47: 464-72.
Drury NE, Licari G, Chong C-R, Howell NJ, Frenneaux MP, Horowitz JD, Pagano D and Sallustio BC. Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake. Br J Clin Pharmacol 2014; 77: 789-95.
Drury NE, Maniakis-Grivas G, Rogers VJ, Williams LK, Pagano D and Martin-Ucar AE. The fate of abstracts presented at annual meetings of the Society for Cardiothoracic Surgery in Great Britain and Ireland from 1993 to 2007. Eur J Cardiothorac Surg 2012; 42: 885-9.
Howell NJ, Ashrafian H, Drury NE, Ranasinghe AM, Contractor H, Isackson H, Calvert M, Williams LK, Freemantle N, Quinn DW, Green D, Frenneaux MP, Bonser RS, Mascaro JG, Graham TR, Rooney SJ, Wilson IC and Pagano D. Glucose-Insulin-Potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose and Electrolytes (HINGE) trial. Circulation 2011; 123: 170-7.
Nassimizadeh M, Ashrafian H, Drury NE, Howell NJ, Digby J, Pagano D, Frenneaux MP and Born GVR. Reduced negative surface charge on arterial endothelium explains accelerated atherosclerosis in type 2 diabetic patients. Diab Vasc Dis Res 2010; 7: 213-5.